These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1372765)
1. Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Garbe C; Kreuser ED; Zouboulis CC; Stadler R; Orfanos CE Semin Oncol; 1992 Apr; 19(2 Suppl 4):63-9. PubMed ID: 1372765 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma. Garbe C Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093 [TBL] [Abstract][Full Text] [Related]
3. [Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Garbe C; Zouboulis CC; Krüger S; Waibel M; Kreuser ED; Stadler R; Orfanos CE Hautarzt; 1992 Jan; 43(1):4-10. PubMed ID: 1369746 [TBL] [Abstract][Full Text] [Related]
4. A feasibility study using polychemotherapy (cisplatin + vindesine + dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma. Bajetta E; Del Vecchio M; Vitali M; Martinetti A; Ferrari L; Queirolo P; Sertoli MR; Cainelli T; Cellerino R; Cascinelli N Tumori; 2001; 87(4):219-22. PubMed ID: 11693798 [TBL] [Abstract][Full Text] [Related]
5. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma. Flaherty LE Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653 [TBL] [Abstract][Full Text] [Related]
6. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial. Ringborg U; Jungnelius U; Hansson J; Strander H Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126 [TBL] [Abstract][Full Text] [Related]
7. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma. Buzaid AC; Legha SS Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096 [TBL] [Abstract][Full Text] [Related]
8. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888 [TBL] [Abstract][Full Text] [Related]
9. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a]. Kirchner HH; Atzpodien J; Poliwoda H Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119 [TBL] [Abstract][Full Text] [Related]
10. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma. Atkins MB; Gollob JA; Sosman JA; McDermott DF; Tutin L; Sorokin P; Parker RA; Mier JW Clin Cancer Res; 2002 Oct; 8(10):3075-81. PubMed ID: 12374674 [TBL] [Abstract][Full Text] [Related]
11. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Keilholz U; Stoter G; Punt CJ; Scheibenbogen C; Lejeune F; Eggermont AM Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S22-8. PubMed ID: 9457389 [TBL] [Abstract][Full Text] [Related]
12. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma. McDermott DF; Mier JW; Lawrence DP; van den Brink MR; Clancy MA; Rubin KM; Atkins MB Clin Cancer Res; 2000 Jun; 6(6):2201-8. PubMed ID: 10873069 [TBL] [Abstract][Full Text] [Related]
13. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
14. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience. Legha SS; Ring S; Eton O; Bedikian A; Plager C; Papadopoulos N Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S9-15. PubMed ID: 9457387 [TBL] [Abstract][Full Text] [Related]
15. Current therapy for malignant melanoma. Legha SS Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575 [TBL] [Abstract][Full Text] [Related]
16. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA). Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035 [TBL] [Abstract][Full Text] [Related]
17. [Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma]. Mansat-Krzyzanowska E; Dreno B Ann Dermatol Venereol; 1994; 121(12):884-7. PubMed ID: 7632005 [TBL] [Abstract][Full Text] [Related]
18. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study. Ringborg U; Rudenstam CM; Hansson J; Hafström L; Stenstam B; Strander H Med Oncol Tumor Pharmacother; 1989; 6(4):285-9. PubMed ID: 2693850 [TBL] [Abstract][Full Text] [Related]
19. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
20. Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. Atkins MB; O'Boyle KR; Sosman JA; Weiss GR; Margolin KA; Ernest ML; Kappler K; Mier JW; Sparano JA; Fisher RI J Clin Oncol; 1994 Aug; 12(8):1553-60. PubMed ID: 8040667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]